Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
R-(-)-gossypol (AT 101)
i
Other names:
AT 101, AT-101, R-(-)-gossypol acetic acid, (-)-gossypol
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Ascentage Pharma
Drug class:
Bcl2 inhibitor, MCL1 inhibitor, Bcl-xL inhibitor
Related drugs:
‹
venetoclax (383)
paclitaxel (163)
albumin-bound paclitaxel (57)
ABT 263 (16)
APG-2575 (7)
APG-1252 (6)
micellar paclitaxel (3)
APG1244 (2)
BGB-11417 (1)
paclitaxel oral (1)
oral paclitaxel/encequidar (1)
S55746 (1)
S63845 (17)
FL118 (9)
AZD5991 (4)
omacetaxine mepesuccinate (3)
AMG 176 (3)
PRT1419 (2)
APG-3526 (1)
A-1331852 (5)
venetoclax (383)
paclitaxel (163)
albumin-bound paclitaxel (57)
ABT 263 (16)
APG-2575 (7)
APG-1252 (6)
micellar paclitaxel (3)
APG1244 (2)
BGB-11417 (1)
paclitaxel oral (1)
oral paclitaxel/encequidar (1)
S55746 (1)
S63845 (17)
FL118 (9)
AZD5991 (4)
omacetaxine mepesuccinate (3)
AMG 176 (3)
PRT1419 (2)
APG-3526 (1)
A-1331852 (5)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
BCL2 overexpression + MCL1 overexpression
Gastroesophageal Cancer
BCL2 overexpression + MCL1 overexpression
Gastroesophageal Cancer
AT 101
Sensitive: D – Preclinical
AT 101
Sensitive
:
D
AT 101
Sensitive: D – Preclinical
AT 101
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login